An LDL That Has Not Fallen Enough on a Statin
Statins work by a proportional reduction, not by moving everyone to the same number, so the useful question is how far your value came down from where it started. NICE sets a greater than 40% reduction in non-HDL cholesterol as the primary-prevention target, checked 2 to 3 months after starting or changing treatment. The two situations that look identical on the report have almost nothing in common: a partial fall means the dose or the drug; no fall at all usually means the tablets are not being absorbed or not being taken.
The pattern on your report
- LDL cholesterol High · moderate Key
- Total cholesterol High Key
- Triglycerides Normal Key
- TSH Normal Key
Printed as: LDL cholesterol in mmol/Lor mg/dL— Usually calculated rather than measured, and the calculation becomes unreliable when triglycerides are raised.Total cholesterol in mmol/Lor mg/dL— Subtracting HDL from this gives non-HDL cholesterol, which is what the treatment target is set on.Triglycerides in mmol/Lor mg/dLTSH in mIU/Lor uIU/mL— The secondary cause most often left unchecked, and it works directly against the treatment.
Why the numbers look like this
Statins block the liver's own cholesterol production. The liver responds by pulling more LDL out of the blood to compensate, which is where most of the reduction comes from.
That mechanism has a specific consequence for dosing. Each doubling of the dose adds only a small further reduction, because the pathway is already largely blocked, so moving up the dose ladder gives diminishing returns while side effects continue to accumulate. Switching to a more potent statin, or adding a drug that works by a different route, achieves more than doubling again.
The pretreatment value is therefore the number everything is measured against, and its absence is why so many of these conversations go nowhere. Without it, nobody can tell a 45% reduction from no reduction at all.
If the fall is genuinely absent, the pathway is not being blocked. Either the drug is not reaching the liver, or something else is driving the LDL up at the same rate the statin brings it down.
Not being flagged is not the same as normal
Non-HDL cholesterol is the value guidelines now use for this check, and it has a practical advantage: it is calculated by subtracting HDL from total cholesterol, so it does not depend on the estimated LDL and it does not require fasting. Where LDL is reported as a calculated value it becomes unreliable when triglycerides are high, which is precisely the situation in which people are most often told their treatment is failing. A directly measured LDL or the non-HDL figure avoids that trap.
What else on the report can hide this
Find the pretreatment result first. Everything else is guesswork without it.
Then ask about the tablets in a way that makes an honest answer easy. Not taking them is the single commonest reason and it is under-reported everywhere. Muscle aches, the fear of them, and stopping after reading about them account for a large share.
The secondary causes are worth excluding once, since each raises LDL against the treatment. Between them a TSH, a urine albumin-to-creatinine ratio, a liver panel and an HbA1c cover the thyroid, the kidney, the bile ducts and glucose handling.
Interactions matter with some statins more than others. Certain antibiotics, antifungals and grapefruit affect how some statins are metabolized, and a few drugs reduce their effect instead.
When the response is genuinely inadequate on a maximal tolerated dose, the answer is to add rather than to keep escalating. Ezetimibe works by blocking absorption from the gut, a different route entirely, and further options exist beyond it. Being told the statin has failed is not the same as running out of treatment.
What usually causes it
Listed from most to least common — not from most to least serious.
- Very common
Not taking the tablets
The commonest reason by a wide margin, and the one least often established. Muscle aches, the fear of them, and media coverage all contribute, and none of it is a character failing.
- Very common
The dose or the statin is not potent enough
A partial fall that stops short of target. Switching to a more potent statin achieves more than doubling the current one.
- Common
No pretreatment value to compare against
Not a biological cause but the reason the question cannot be answered. Retrieving the earlier result often ends the discussion.
- Common
An underactive thyroid
Raises LDL and works against the treatment. A TSH is cheap and it is the secondary cause most often forgotten.
- Common
Protein loss through the kidney
Drives the liver to overproduce lipoproteins. A urine albumin-to-creatinine ratio identifies it.
- Common
Familial hypercholesterolemia
A very high starting value that falls proportionally but remains high. It needs more than a statin alone, and it needs family testing.
- Common
A calculated LDL distorted by high triglycerides
The estimate becomes unreliable when triglycerides are raised. Non-HDL cholesterol or a directly measured LDL avoids it.
- Uncommon
Drug interactions
Some statins are affected by particular antibiotics, antifungals and grapefruit; a few drugs reduce their effect. A medication review identifies it.
- Uncommon
Cholestatic liver disease
A raised ALP with a raised cholesterol. The lipid abnormality follows the bile flow problem and responds to treating that.
What is usually checked next
- The pretreatment lipid result The reduction is proportional, so without a starting point the current value cannot be judged at all.
- Non-HDL cholesterol rather than calculated LDL It does not depend on the LDL estimate and it does not need fasting, which removes two sources of error.
- An open conversation about how the tablets are actually taken The commonest cause, and the answer depends entirely on how the question is asked.
- TSH, urine ACR, liver panel and HbA1c Covers the secondary causes that raise LDL against the treatment, in one round.
- A medication review for interactions Several common drugs alter how particular statins work, in both directions.
When to seek care sooner
- Emergency Severe muscle pain and weakness, especially with dark urine
- Same day Chest pain or breathlessness on exertion
- Same day Yellowing of the eyes with abdominal pain
- Soon Fatty deposits in the skin, or a white ring around the cornea when young
- Soon A close relative with a heart attack before their mid-fifties
- Soon An LDL that has not moved at all since starting
Questions worth bringing to your appointment
- What was my cholesterol before I started the statin?
- What percentage has it fallen by?
- Has my non-HDL cholesterol been calculated rather than just the LDL?
- Have my thyroid, kidney and liver been checked?
- Would adding a second medicine work better than increasing this one?